Document ID: chunk:federal_register_of_legislation:F2024L01547:schedule:1:p1
Version: federal_register_of_legislation:F2024L01547
Segment Type: schedule
Provision Reference: sch 1 (pt 1/3)
Character Range: 2247–5951

Schedule 1 – Amendments

National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022)

        1.                  Schedule 1 – entry for Amlodipine with valsartan
       Omit
Amlodipine with valsartan  Tablet 5 mg (as besilate)‑80 mg    Oral  Exforge 5/80    28  7.42   11.14
                           Tablet 5 mg (as besilate)‑160 mg   Oral  Exforge 5/160   28  9.31   13.03
                           Tablet 5 mg (as besilate)‑320 mg   Oral  Exforge 5/320   28  11.72  15.44
                           Tablet 10 mg (as besilate)‑160 mg  Oral  Exforge 10/160  28  9.80   13.52
                           Tablet 10 mg (as besilate)‑320 mg  Oral  Exforge 10/320  28  11.91  15.63

       Insert
Amlodipine with valsartan  Tablet 5 mg (as besilate)‑80 mg    Oral  Exforge 5/80    28  7.42   13.00
                           Tablet 5 mg (as besilate)‑160 mg   Oral  Exforge 5/160   28  9.31   14.89
                           Tablet 5 mg (as besilate)‑320 mg   Oral  Exforge 5/320   28  11.72  17.30
                           Tablet 10 mg (as besilate)‑160 mg  Oral  Exforge 10/160  28  9.80   15.38
                           Tablet 10 mg (as besilate)‑320 mg  Oral  Exforge 10/320  28  11.91  17.49

        1.                  Schedule 1 – entry for Amlodipine with valsartan and hydrochlorothiazide
       Omit
Amlodipine with valsartan and hydrochlorothiazide  Tablet 5 mg (as besilate)‑160 mg‑12.5 mg   Oral  Exforge HCT 5/160/12.5   28  10.72  20.02
                                                   Tablet 5 mg (as besilate)‑160 mg‑25 mg     Oral  Exforge HCT 5/160/25     28  12.13  15.85
                                                   Tablet 10 mg (as besilate)‑160 mg‑12.5 mg  Oral  Exforge HCT 10/160/12.5  28  11.21  14.93
                                                   Tablet 10 mg (as besilate)‑160 mg‑25 mg    Oral  Exforge HCT 10/160/25    28  12.62  21.92
                                                   Tablet 10 mg (as besilate)‑320 mg‑25 mg    Oral  Exforge HCT 10/320/25    28  14.73  18.45

       Insert
Amlodipine with valsartan and hydrochlorothiazide  Tablet 5 mg (as besilate)‑160 mg‑12.5 mg   Oral  Exforge HCT 5/160/12.5   28  10.72  21.88
                                                   Tablet 5 mg (as besilate)‑160 mg‑25 mg     Oral  Exforge HCT 5/160/25     28  12.13  17.71
                                                   Tablet 10 mg (as besilate)‑160 mg‑12.5 mg  Oral  Exforge HCT 10/160/12.5  28  11.21  16.79
                                                   Tablet 10 mg (as besilate)‑160 mg‑25 mg    Oral  Exforge HCT 10/160/25    28  12.62  23.78
                                                   Tablet 10 mg (as besilate)‑320 mg‑25 mg    Oral  Exforge HCT 10/320/25    28  14.73  20.31

        1.                  Schedule 1 – entry for Brinzolamide
       Omit
Brinzolamide  Eye drops 10 mg per mL, 5 mL  Application to the eye  Azopt  1  9.06  12.10

       Insert
Brinzolamide  Eye drops 10 mg per mL, 5 mL  Application to the eye  Azopt  1  9.06  13.52

        1.                  Schedule 1 – entry for Carbamazepine
       Omit
Carbamazepine  Tablet 100 mg  Oral  Tegretol 100  100  4.85  6.08
               Tablet 200 mg  Oral  Tegretol 200  100  8.10  9.32

       Insert
Carbamazepine  Tablet 100 mg  Oral  Tegretol 100  100  4.85  6.98
               Tablet 200 mg  Oral  Tegretol 200  100  8.10  10.24

        1.                  Schedule 1 – entry for Ciprofloxacin
       Omit
Ciprofloxacin  Eye drops 3 mg (as hydrochloride) per mL, 5 mL  Application to the eye  Ciloxan  1  8.92  10.95

       Insert
Ciprofloxacin  Eye drops 3 mg (as hydrochloride) per mL, 5 mL  Application to the eye